Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma.

Autor: Gupta M; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA.; Department of Neurosurgery, University of California San Diego, La Jolla, CA., Bradley JD; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Massaad E; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Burns EJ; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Georgantas NZ; Department of Pathology, Massachusetts General Hospital, Boston, MA., Maron GE; Department of Pathology, Massachusetts General Hospital, Boston, MA., Batten JM; Department of Pathology, Massachusetts General Hospital, Boston, MA., Gallagher A; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Thierauf J; Department of Pathology, Massachusetts General Hospital, Boston, MA.; Department of Otorhinolaryngology, Head and Neck Surgery, Experimental Head and Neck Oncology, Heidelberg University Hospital, Heidelberg, Germany., Nayyar N; Cancer Center, Massachusetts General Hospital, Boston, MA., Gordon A; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, MA., Jones SS; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, MA., Pisapia M; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, MA., Sun Y; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, MA., Jones PS; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Barker FG 2nd; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Curry WT; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Gupta R; Department of Neuroradiology, Massachusetts General Hospital, Boston, MA., Romero JM; Department of Neuroradiology, Massachusetts General Hospital, Boston, MA., Wang N; Department of Medicine, Massachusetts General Hospital, Boston, MA., Brastianos PK; Cancer Center, Massachusetts General Hospital, Boston, MA.; Department of Neurology, Massachusetts General Hospital, Boston, MA.; Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA., Martinez-Lage M; C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, Boston, MA., Tateishi K; Department of Neurosurgery, Yokohama City University, Yokohama, Japan., Forst DA; Cancer Center, Massachusetts General Hospital, Boston, MA., Nahed BV; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Batchelor TT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA., Ritterhouse LL; Department of Pathology, Massachusetts General Hospital, Boston, MA., Iser F; Department of Neurology and Neuro-Oncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kessler T; Department of Neurology and Neuro-Oncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Jordan JT; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, MA., Dietrich J; Cancer Center, Massachusetts General Hospital, Boston, MA.; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, MA., Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Cahill DP; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Lennerz JK; Department of Pathology, Massachusetts General Hospital, Boston, MA., Carter BS; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Shankar GM; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA.

Publikováno v: Blood [Blood] 2024 Sep 05; Vol. 144 (10), pp. 1093-1100.